T1 and susceptibility contrast at high fields

Clinical imaging at high magnetic field strengths (≥ 3Tesla) is sought after primarily due to the increased signal strength available at these fields. This increased SNR can be used to perform: (a) high resolution imaging in the same time as at lower field strengths; (b) the same resolution imaging with much faster acquisition; and (c) functional MR imaging (fMRI), dynamic perfusion and diffusion imaging with increased sensitivity. However they are also associated with increased power deposition (SAR) due to increase in imaging frequency and longer T1 relaxation times. Longer T1s mean longer imaging times for generating good T1 contrast images. On the other hand for faster imaging, at high fields fast spin echo or magnetization prepared sequences are conventionally proposed which are, however, associated with high SAR values. Imaging with low SAR is more and more important as we move towards high fields and particularly for patients with metallic implants like pacemakers or deep brain stimulator. The SAR limit acceptable for these patients is much less than the limit acceptable for normal subjects. A new method is proposed for imaging at high fields with good contrast with simultaneous reduction in power deposition.;Further, T1 based contrast optimization problem in FLASH imaging is considered for tissues with different T1s but same spin densities. The solution providing optimal imaging parameters is simplified for quick and easy computation in a clinical setting. The efficacy of the simplification is evaluated and practical limits under which the simplification can be applied are worked out.;The phase difference due to variation in magnetic susceptibility property among biological tissues is another unique source of contrast which is different from the conventional T1, T2 and T2* contrast. This susceptibility based phase contrast has become more and more important at high fields, partly due to contrast generation issues due to longer T 1s and shorter T2s and partly because of the invariance of most tissue susceptibilities with field strength. This essentially ensures a constant available phase contrast between tissues across field strengths. In fact, with the increased SNR at high fields, the phase CNR actually increases with field strength which is even better. Susceptibility weighted imaging, which uniquely combines this phase and magnitude information to generate enhanced susceptibility contrast magnitude images, has proven to be an important tool in the study of various neurological conditions like, Alzheimer's, Parkinson's, Huntington's disease and multiple sclerosis even at conventional field strength of 1.5T and should have more applicability at high fields. A major issue in using phase images for susceptibility contrast, directly or as processed SWI magnitude images, is the large scale background phase variations that obscure the local susceptibility based contrast. A novel method is proposed for removing such geometrically induced large scale phase variations using a Fourier Transform based field calculation method. It is shown that the new method is capable of successfully removing the background field effects. It is shown that the new method is not only capable of successfully removing the background field effects but also helps in preserving more local phase information.